Tavexia Lifecare Board Approves Meyonex Acquisition Proposal and Auditor Transition
Sattva Sukun Lifecare Ltd 路 Others (Uncategorized) 路 08 Sept 2026, 1:00 am
Tavexia Lifecare Board Approves Meyonex Acquisition Proposal and Auditor Transition Tavexia Lifecare's board authorized evaluating and negotiating the acquisition of up to a 60% equity stake in Meyonex Pharmaceuticals Ltd, which has a paid-up capital of Rs 13.99 cr. Additionally, the board accepted the resignation of statutory auditor M/s SSRV & Associates effective 7th Sep'26 and approved the appointment of M/s DEVAM & Associates LLP for a five-year term (FY27 to FY31), subject to shareholder approval. The board also approved the reappointment of Independent Director Khushboo Vasudev for a second five-year term.
Original exchange filing (PDF)
More announcements from Sattva Sukun Lifecare Ltd
- Financial Result 路 05 Nov 2026
- Announcement 路 05 Nov 2026
- Board has Approved in Change in RTA 路 05 Nov 2026
- Result 路 05 Nov 2026
- Outcome of Board Meeting 路 05 Nov 2026
- Tavexia Lifecare Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 04/11/2026 ,inter alia, to consider and approve Intimation of Board Meeting 路 04 Nov 2026
- Announcement 路 13 Oct 2026
- Disclosure under regulation 30 路 12 Oct 2026
